Sign in
Taking people in United StatesPhase 3

PREcision MEDicine In Achalasia (PREMEDIA)

Key facts

Who runs it
Northwestern University
Where
Atlanta, Baltimore, Boston, Charlotte, Chicago, Cleveland, Dallas, Denver, Gainesville, La Jolla, Nashville, New York, Orlando, Scottsdale, and St Louis, United StatesSee the 16 sites
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
372 people, planned
Started
29 Apr 2026
Expected to end
1 Aug 2032
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Standard Myotomy
  • Tailored Short Myotomy
Record updated
12 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 20 criteriaShow less

Who can take part

  • Age ≥ 18
  • Type I achalasia or type II achalasia or cEGJOO
  • Eckardt score > 3

Who cannot take part

  • Prior POEM
  • Prior surgical treatment for achalasia
  • Prior unrelated esophageal or upper gastric surgery, including Roux-en-Y gastric bypass and sleeve gastrectomy
  • Prior endoscopic gastroesophageal intervention for obesity or GERD, such endoscopic sleeve gastroplasty or transoral incisionless fundoplication
  • Fibroinflammatory stricture of the esophagus due to any etiology (e.g., peptic, radiation, eosinophilic)
  • Weekly (or more frequent) opioid medication use in the last 2 years
  • Known secondary achalasia related to malignancy (pseudoachalasia)
  • The following exclusion criteria are for the RCT, but 1-13 below also pertain to the observational study:
  • Endoscopic pneumatic dilation or lower esophageal sphincter botulinum toxin (botox) injection within 6 months
  • Known eosinophilic esophagitis
  • Diverticulum (> 2 cm) in distal esophagus
  • Megaesophagus
  • Pregnancy
  • Standard contraindications to general anesthesia
  • Standard contraindications to endoscopic myotomy in the esophagus (e.g. untreated varices)
  • Unwillingness or inability to consent for the study
  • Anticipated inability to follow protocol

Where in United States

  • Emory UniversityAtlanta, United StatesContact: Halley Fowler, Lead Study CoordinatorTaking people
  • Johns Hopkins UniversityBaltimore, United StatesContact: Elizabeth Yan, BSNot yet recruiting
  • Massachusetts General HospitalBoston, United StatesContact: Madison Paylor, Lead Study CoordinatorTaking people
  • Atrium Health - Wake ForestCharlotte, United StatesContact: Greg Scarola, Lead Study CoordinatorTaking people
  • Northwestern UniversityChicago, United StatesContact: Eric Pfannkuche, Lead Study CoordinatorTaking people
  • Case Western Reserve UniversityCleveland, United StatesContact: Elizabeth Yan, BSNot yet recruiting
  • MetroHealth Medical CenterCleveland, United StatesContact: Stephanie Baker, Lead Study CoordinatorTaking people
  • Baylor Scott & White HealthDallas, United StatesContact: Neomy Flores, Lead Study CoordinatorTaking people
  • University of Colorado DenverDenver, United StatesContact: Elizabeth Yan, BSNot yet recruiting
  • University of FloridaGainesville, United StatesContact: April Goddard, Lead Study Coordinator, PA-CTaking people
  • University of California San DiegoLa Jolla, United StatesContact: Alexander Gonsalves, Lead Study CoordinatorTaking people
  • Vanderbilt University Medical CenterNashville, United StatesContact: Larry Raber, Lead Study CoordinatorTaking people
  • Weill Cornell Medical CollegeNew York, United StatesContact: Elizabeth Yan, BSNot yet recruiting
  • Adventist Health System/Sunbelt, Inc.Orlando, United StatesContact: Elizabeth Yan, BSNot yet recruiting
  • Mayo Clinic - ArizonaScottsdale, United StatesContact: Elizabeth Yan, BSNot yet recruiting
  • Washington UniversitySt Louis, United StatesContact: Darren Nix, Lead Study CoordinatorTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if shorter Per-Oral Endoscopic Myotomy (POEM) works as well as a longer POEM in patients with trouble swallowing due to certain conditions. The main question[s] it aims to answer [is/are]:

Read full original descriptionShow less

* Does making a smaller cut in the muscle at the bottom of the esophagus work just as well as making the standard bigger cut in relieving symptoms? * Does making the smaller cut reduce the side effects of the procedure compared to the standard bigger cut? Researchers will compare the symptoms and side effects of making a shorter cut to the symptoms and side effects of a longer cut.

Participants will allow researchers to access their standard of care information in their medical record, complete questionnaires at up to 6 times over a 2-year period.

The 2 groups in the trial

  • Standard MyotomyExisting treatment, for comparison
  • Tailored Short MyotomyTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
PREcision MEDicine In Achalasia - A Multicenter Randomized Non-Inferiority Clinical Trial of Short Tailored POEM vs. Standard POEM for Non-Spastic Achalasia and A Multicenter Prospective Cohort Study of Long Tailored POEM for Spastic Esophageal Motility Disorders
Record updated
12 November 2026